MA31145B1 - Composition antivirale et procede d'utilisation - Google Patents

Composition antivirale et procede d'utilisation

Info

Publication number
MA31145B1
MA31145B1 MA32065A MA32065A MA31145B1 MA 31145 B1 MA31145 B1 MA 31145B1 MA 32065 A MA32065 A MA 32065A MA 32065 A MA32065 A MA 32065A MA 31145 B1 MA31145 B1 MA 31145B1
Authority
MA
Morocco
Prior art keywords
antiviral composition
lambdacarrageenan
iota
kappa
prophylaxis
Prior art date
Application number
MA32065A
Other languages
English (en)
Inventor
Andreas Grassauer
Christiane Meier
Eva Prieschl-Grassauer
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39383268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31145(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en
Priority claimed from EP06450176A external-priority patent/EP1930015A1/fr
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of MA31145B1 publication Critical patent/MA31145B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Paper (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

La présente invention porte sur l'utilisation de iota-, kappa- ou lambdacarragénine ou des mélanges de celles-ci pour la fabrication d'une composition pharmaceutique antivirale utile dans la prophylaxie ou le traitement d'une infection rhinovirale.
MA32065A 2006-12-05 2009-07-02 Composition antivirale et procede d'utilisation MA31145B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/567,078 US20080131454A1 (en) 2006-12-05 2006-12-05 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
EP06450176A EP1930015A1 (fr) 2006-12-05 2006-12-05 Utilisation de carraghénine pour traiter les infections causées par le rhinovirus

Publications (1)

Publication Number Publication Date
MA31145B1 true MA31145B1 (fr) 2010-02-01

Family

ID=39383268

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32065A MA31145B1 (fr) 2006-12-05 2009-07-02 Composition antivirale et procede d'utilisation

Country Status (23)

Country Link
EP (1) EP2101792B1 (fr)
JP (1) JP5470047B2 (fr)
KR (1) KR101437708B1 (fr)
CN (1) CN101678040B (fr)
AT (1) ATE462438T1 (fr)
AU (1) AU2007327934B2 (fr)
BR (1) BRPI0720054A2 (fr)
CA (1) CA2671317C (fr)
CY (1) CY1110658T1 (fr)
DE (1) DE602007005697D1 (fr)
DK (1) DK2101792T3 (fr)
EA (1) EA015930B1 (fr)
ES (1) ES2343701T3 (fr)
IL (1) IL198810A (fr)
MA (1) MA31145B1 (fr)
MX (1) MX2009005838A (fr)
NO (1) NO342681B1 (fr)
NZ (1) NZ577063A (fr)
PL (1) PL2101792T3 (fr)
PT (1) PT2101792E (fr)
SI (1) SI2101792T1 (fr)
TN (1) TN2009000211A1 (fr)
WO (1) WO2008067982A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000437A1 (fr) * 2008-07-01 2010-01-07 Marinomed Biotechnologie Gmbh Biopolymères antiallergiques marins
JP5702526B2 (ja) 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
AU2010335594B2 (en) 2009-12-22 2015-05-21 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
JP5900030B2 (ja) 2011-03-08 2016-04-06 凸版印刷株式会社 防湿容器
EP2898888B8 (fr) * 2014-01-22 2019-06-12 VISUfarma B.V. Composition contenant de la carraghénane contre la conjonctivite virale
CN107847430B (zh) 2015-07-14 2021-02-02 玛丽诺姆德生物技术股份公司 一种具有抗病毒活性的鼻塞疏通组合物
UA118192C2 (uk) * 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en) 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN111437270A (zh) * 2020-04-24 2020-07-24 瑞希(重庆)生物科技有限公司 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
EP4210670A1 (fr) 2020-09-08 2023-07-19 Altamira Medica, AG Compositions pour prévenir une infection
KR102720037B1 (ko) * 2021-12-21 2024-10-22 (주)메디코어 비강 세정제 조성물 및 그 제조방법
WO2025067689A1 (fr) 2023-09-26 2025-04-03 Metriopharm Ag 5-amino-2,3-dihydro-1,4-phtalazinedione pour le traitement d'infections par un virus à arn
WO2025114567A1 (fr) * 2023-11-30 2025-06-05 Université De Strasbourg Biomatériau à propriétés antibactériennes et antivirales simultanées

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1307189B1 (fr) 2000-07-28 2006-05-10 Immupharm APS Utilisation d'hydroxyethylrutosides pour traiter les symptomes du rhume, la rhinite allergique et les infections liees aux voies respiratoires
US6953483B2 (en) * 2002-03-05 2005-10-11 Litke Kenneth S Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
CN1194981C (zh) * 2002-07-22 2005-03-30 青岛海洋大学 卡拉胶低聚糖的制备方法
CN101385740B (zh) * 2003-05-26 2011-06-08 福州大学 多糖硫酸酯作为制备抗流感病毒药物的应用
WO2005004882A1 (fr) * 2003-07-09 2005-01-20 Monash University Polymeres charges antiviraux presentant une resistance a la degradation lysosomale pendant une filtration renale et un passage renal, compositions et methodes d'utilisation correspondantes
WO2006003521A1 (fr) * 2004-02-06 2006-01-12 Monash University Utilisation a haute dose et sur un intervalle court de polysaccharides sulfates dans le traitement des infections
DE202005014019U1 (de) * 2005-09-05 2005-11-24 G. Pohl-Boskamp Gmbh & Co. Kg Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) * 2006-03-06 2006-06-05 Paolo Ottier Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de) 2006-07-07 2008-01-17 Leoni Ag Sensorsystem und Sensorelement

Also Published As

Publication number Publication date
CA2671317C (fr) 2015-03-17
DE602007005697D1 (de) 2010-05-12
PT2101792E (pt) 2010-06-25
JP2010512307A (ja) 2010-04-22
BRPI0720054A2 (pt) 2013-12-17
KR101437708B1 (ko) 2014-09-03
CN101678040B (zh) 2012-10-03
EP2101792B1 (fr) 2010-03-31
KR20090096598A (ko) 2009-09-11
SI2101792T1 (sl) 2010-08-31
ES2343701T3 (es) 2010-08-06
TN2009000211A1 (en) 2010-10-18
AU2007327934B2 (en) 2013-04-18
JP5470047B2 (ja) 2014-04-16
NZ577063A (en) 2011-05-27
HK1141980A1 (en) 2010-11-26
EA015930B1 (ru) 2011-12-30
AU2007327934A1 (en) 2008-06-12
EP2101792A2 (fr) 2009-09-23
WO2008067982A3 (fr) 2009-04-16
CN101678040A (zh) 2010-03-24
MX2009005838A (es) 2009-06-16
ATE462438T1 (de) 2010-04-15
EA200970529A1 (ru) 2009-12-30
CA2671317A1 (fr) 2008-06-12
CY1110658T1 (el) 2015-06-10
WO2008067982A2 (fr) 2008-06-12
DK2101792T3 (da) 2010-07-26
IL198810A0 (en) 2010-02-17
PL2101792T3 (pl) 2010-11-30
NO20091955L (no) 2009-09-04
IL198810A (en) 2013-03-24
NO342681B1 (no) 2018-07-02

Similar Documents

Publication Publication Date Title
TN2009000211A1 (en) Antiviral composition and method of use
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
MX337081B (es) Anticuerpo anti-nr10 y su uso.
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
MX2010002296A (es) Inhibidores iv de polimerasa de fosfadiazina hcv.
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
EP1750667A4 (fr) Combinaison de fosfomycine/aminoglycoside aerosolisé pour le traitement d'infections respiratoires bactériennes
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
CL2007003281A1 (es) Compuesto 1-(4-metilfenil)dihidro-1h-pirrolo[1,2-a]imidazol-2,5-(3h,6h)-diona; composicion farmaceutica; y uso para el tratamiento terapeutico o preventivo de la neurotoxicidad periferica inducida por quimioterapeuticos.
AR046245A1 (es) Sales de calcio de rabeprazol
PL1837029T3 (pl) Kompozycja farmaceutyczna do zapobiegania i leczenia przeziębień
EP1474524A4 (fr) Substitut cartilagineux pour la recherche medicamenteuse
ATE482198T1 (de) Sitamaquintosylat zur behandlung von leishmaniase
ATE424834T1 (de) Zellulosesulfat zur behandlung von rhinovirus- infektionen
DE602005011029D1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
UA39498U (ru) Способ лечения системной красной волчанки